One possibility is that elevated levels of SFTPB in HDL are a marker for impaired capillary barrier function, perhaps because of microvascular injury, that affects both the lungs and cardiovascular system in patients with T1DM. This evidence concerns the gene SFTPB and type 1 diabetes mellitus.